Literature DB >> 8905623

Anatomical distribution of NADPH-cytochrome P450 reductase and cytochrome P4502D forms in rat brain: effects of xenobiotics and sex steroids.

A F Bergh1, H W Strobel.   

Abstract

Since the brain is not a homogeneous organ, but one dependent upon the well orchestrated interaction of numerous parts, pathology in one nucleus may have a large impact upon its overall function. Hence, the anatomical distribution of the P450 monoxygenase system in brain, as well as the regulation of its expression, is important in elucidating its function in that organ. In order to study these issues, female rats-both ovariectomized and not-were treated with a number of xenobiotic compounds and sex steroids. The brains from these animals were dissected into 8 discrete regions and the presence and relative level of message for P4502D and P450 reductase determined using polymerase chain reaction. Results of this investigation indicate the presence of mRNA for reductase and P4502D isoforms throughout the rat brain. In addition, quantitative PCR was utilized to demonstrate the effects of xenobiotics (phenobarbital, beta-naphthoflavone, imipramine) and sex hormones (testosterone, estrogen) on the levels of these messages in the female rat brain. Significant induction of message for P4502D forms was noted with testosterone in the absence of estrogen. The level of mRNA for reductase was not significantly influenced by any of the treatments, however. These results raise the issue of a sexual dimorphism in the rat regarding P4502D expression in brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905623     DOI: 10.1007/bf00250993

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction.

Authors:  T Horikoshi; K D Danenberg; T H Stadlbauer; M Volkenandt; L C Shea; K Aigner; B Gustavsson; L Leichman; R Frösing; M Ray
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

2.  p1B15: a cDNA clone of the rat mRNA encoding cyclophilin.

Authors:  P E Danielson; S Forss-Petter; M A Brow; L Calavetta; J Douglass; R J Milner; J G Sutcliffe
Journal:  DNA       Date:  1988-05

3.  Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain.

Authors:  B Schilter; C J Omiecinski
Journal:  Mol Pharmacol       Date:  1993-11       Impact factor: 4.436

4.  Quantitation of enteroviral RNA by competitive polymerase chain reaction.

Authors:  T A Martino; M J Sole; L Z Penn; C C Liew; P Liu
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

5.  Alterations in rat hepatic drug metabolism during pregnancy and lactation.

Authors:  J T Borlakoglu; A Scott; C J Henderson; C R Wolf
Journal:  Biochem Pharmacol       Date:  1993-07-06       Impact factor: 5.858

6.  Ontogeny of aromatase messenger ribonucleic acid in mouse brain: fluorometrical quantitation by polymerase chain reaction.

Authors:  N Harada; K Yamada
Journal:  Endocrinology       Date:  1992-11       Impact factor: 4.736

7.  Transcription of the dystrophin gene in human muscle and non-muscle tissue.

Authors:  J Chelly; J C Kaplan; P Maire; S Gautron; A Kahn
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

Review 8.  Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore.

Authors:  K W Gee
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

9.  Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6.

Authors:  A Llerena; G Edman; J Cobaleda; J Benítez; D Schalling; L Bertilsson
Journal:  Acta Psychiatr Scand       Date:  1993-01       Impact factor: 6.392

10.  Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

Authors:  K E Noonan; C Beck; T A Holzmayer; J E Chin; J S Wunder; I L Andrulis; A F Gazdar; C L Willman; B Griffith; D D Von Hoff; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

View more
  3 in total

Review 1.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

2.  Accumulation of mitochondrial P450MT2, NH(2)-terminal truncated cytochrome P4501A1 in rat brain during chronic treatment with beta-naphthoflavone. A role in the metabolism of neuroactive drugs.

Authors:  E Boopathi; H K Anandatheerthavarada; S V Bhagwat; G Biswas; J K Fang; N G Avadhani
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

Review 3.  Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Julio Benitez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.